| # | Drug | Count |
|---|---|---|
| 0 | FLUOROURACIL | 6 |
| 1 | FLUOROURACIL CREAM, 0.5% | 6 |
| 2 | PEMBROLIZUMAB | 6 |
| 3 | ACETAMINOPHEN | 2 |
| 4 | ADALIMUMAB | 2 |
| 5 | ATENOLOL | 2 |
| 6 | CISPLATIN | 2 |
| 7 | CLOZAPINE | 2 |
| 8 | DICLOFENAC | 2 |
| 9 | DICLOFENAC SODIUM | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TISLELIZUMAB-JSGR | 1 | 0.0045 |
| 1 | DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE | 1 | 0.0003 |
| 2 | IRINOTECAN HYDROCHLORIDE | 2 | 0.0002 |
| 3 | BENZTROPINE | 1 | 0.0001 |
| 4 | PEGVALIASE-PQPZ | 1 | 0.0001 |
| 5 | DASATINIB | 1 | 0.0001 |
| 6 | LEUCOVORIN CALCIUM | 2 | 0.0001 |
| 7 | CEFUROXIME | 1 | 0.0001 |
| 8 | SODIUM BICARBONATE INJECTION, | 2 | 0.0001 |
| 9 | CRIZOTINIB | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Phenylalanine Metabolizing Enzyme [EPC] | 1 | 0.0001 |
| 1 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 2 | Parathyroid Hormone-Related Peptide Analog [EPC] | 1 | 0.0000 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 7 | 0.0000 |
| 4 | General Anesthetic [EPC] | 1 | 0.0000 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 | 0.0000 |
| 6 | Platinum-based Drug [EPC] | 4 | 0.0000 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Catecholamine [EPC] | 1 | 0.0000 |
| 9 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |